Board of Directors
Combining many years of lateral flow industry and commercial expertise with a passion to deliver on our mission and vision.
-
Dr Chris Hand
Executive Chairman
Dr Chris Hand is co-founder of Abingdon Health. He has 30 years’ experience in the medical diagnostics industry, in the…
-
Mary Tavener
Non-executive Director
Mary Tavener is the Senior Independent NED of Abingdon Health and Chair of the Audit Committee. She has extensive experience…
-
Dr Katie Brenner
Non-Executive Director
Dr Katie Brenner is an Independent Non-Executive Director at Abingdon Health plc. Dr Brenner is based in Madison, WI, USA and founded…
-
Tom Hayes
Chief Financial Officer
Tom Hayes is the Chief Financial Officer of Abingdon Health. Prior to joining the company, he spent ten years as…
Dr Chris Hand
Executive Chairman
Dr Chris Hand is co-founder of Abingdon Health.
He has 30 years’ experience in the medical diagnostics industry, in the development and commercialisation of immunodiagnostic products, particularly rapid tests.
Chris co-founded the medical diagnostics company Cozart Bioscience Ltd specialising in saliva drug testing, and was Chief Executive of Cozart plc, following IPO on AIM in 2004, until October 2007 when the company was sold to Concateno plc.
Prior to founding Cozart, Chris was Director of Research for the European base of DPC (now part of Siemens Healthcare Solutions) developing a wide range of immunodiagnostic kits in a variety of formats.
He has a BSc in Applied Biochemistry from Brunel University and a DPhil from the Faculty of Medicine, University of Oxford.
Mary Tavener
Non-executive Director
Mary Tavener is the Senior Independent NED of Abingdon Health and Chair of the Audit Committee.
She has extensive experience in the healthcare sector, having previously been Chief Financial Officer and Board member of AIM listed Advanced Medical Solutions plc (AMS) for 19 years during which the company saw 15 years of consecutive growth.
Mary is a Member of the Chartered Institute of Management Accountants (ACMA) and a Fellow of the Association of Corporate Treasurers (FCT).
She has a degree in Chemistry from the University of Oxford.
Dr Katie Brenner
Non-Executive Director
Dr Katie Brenner is an Independent Non-Executive Director at Abingdon Health plc.
Dr Brenner is based in Madison, WI, USA and founded bluDiagnostics, a company specialising in lateral flow testing with an associated app to allow at-home monitoring of female fertility using saliva samples.
She sold bluDiagnostics to Amazon in 2020 and remained there until 2024.
Dr Brenner has a PhD in Bioengineering from Caltech and a BS and MS from Stanford University in Electrical Engineering.
Tom Hayes
Chief Financial Officer
Tom Hayes is the Chief Financial Officer of Abingdon Health.
Prior to joining the company, he spent ten years as Group Finance Director at Northern Bear plc, an AIM-listed Group of ten specialist building services companies.
Tom qualified as a Chartered Accountant with Arthur Andersen & Co and has also held roles with Sentio Insight LLP, a boutique advisory firm providing a range of financial due diligence and transaction services, and Ernst & Young LLP’s transaction advisory services team.
